Printer Friendly

SPECTRASCIENCE GETS $1.1 MILLION FROM WARRANT EXERCISE

 MINNEAPOLIS, Feb. 4, /PRNewswire/ -- SpectraScience, Inc. (NASDAQ: SPSC), announced today that the company has received a total of $1,103,750 in new funds as a result of the exercise by shareholders of 1,471,666 warrants to purchase common stock at 75 cents per share.
 The warrants, originally issued in connection with a $4 million equity financing in February of 1992, were due to expire yesterday. The company's Board of Directors has extended the expiration date on the remaining 5,195,000 warrants for an additional 14 days, until the close of business on Feb. 17.
 "We anticipate that additional warrants will be exercised during the extension period, increasing the funds available for development and the beginning of production of our diagnostic system for coronary artery disease," said Daryl F. Yurek, chairman and chief executive officer. "The new system is generating considerable interest in the medical community, and we expect to bring it to market later this year."
 SpectraScience designs, develops, manufactures and markets laser- enhanced systems for the diagnosis of cardiovascular disease. The company's diagnostic system uses laser-induced fluoroscopy to identify and characterize coronary artery disease.
 -0- 2/4/93
 /CONTACT: Curt Swenson of Swenson Falker Eilertsen Inc., 612-371-0000 or Tom Ahmann of SpectraScience, 612-559-4000/
 (SPSC)


CO: SpectraScience, Inc. ST: Minnesota IN: MTC SU:

DS -- MN006 -- 2783 02/04/93 09:01 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 4, 1993
Words:225
Previous Article:KOHL'S CORPORATION JANUARY SALES REPORT
Next Article:NASA WILL USE POWERFUL CONNECTION MACHINE TO SOLVE GRAND CHALLENGE PROBLEMS IN AEROSCIENCES
Topics:


Related Articles
SPECTRASCIENCE REPORTS THIRD QUARTER RESULTS
SPECTRASCIENCE LASER DIAGNOSTIC SYSTEM USED IN SUCCESSFUL CORONARY PROCEDURE AT CLEVELAND CLINIC
SPECTRASCIENCE GETS TOTAL OF $3,252,998 FROM WARRANT EXERCISE
SPECTRASCIENCE RECEIVES ORDERS FOR NEW DIAGNOSTIC SYSTEM
SPECTRASCIENCE REPORTS FIRST QUARTER RESULTS, CLINICAL PROGRESS
SpectraScience Adds Industry Veteran to Executive Team.
SpectraScience Delivers Cancer Diagnosis System to Mayo Clinic and UCSD/VA for Detecting Esophageal Dysplasia in Patients.
University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia.
SpectraScience, Inc. Enters Into $6.0 Million Common Stock Purchase Agreement.
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters